Dear heads of Japan alumni clubs of Babson, Berkeley, Bocconi, Brown, Cambridge, Columbia, Cornell, UChicago, Dartmouth, Georgetown, MIT, Northwestern, Oxford, Princeton, Science Po, Smith, Stanford, Temple, Tufts, Wellesley, UWisconsin, Yale and Yonsei:
Thanks for your ongoing support of Harvard Club of Japan’s events. We are pleased to invite your members to a talk “Unlocking the commercial and medical potential of Japanese science via entrepreneurship” by Robert Kneller, J.D., M.D., M.P.H., Professor, Research Center for Advanced Science and Technology (RCAST), University of Tokyo. Details follow below and on our website.
We hope you and some of your members can attend.
Harvard Club of Japan
We are pleased to invite your members to a talk “Unlocking the commercial and medical potential of Japanese science via entrepreneurship” by Robert Kneller, J.D., M.D., M.P.H., Professor, Research Center for Advanced Science and Technology (RCAST), University of Tokyo.
Japan is poorly represented in commercial applications of new science and engineering discoveries. New companies are in the global forefront of commercializing new advanced scientific and technological products, but hardly any of these new companies are Japanese. Entrepreneurial Japanese companies in science and engineering face unique challenges not faced by American and even European startups. But Japan offers some advantages, too.
This talk will focus on Dr. Kneller’s experience in trying to open a second path to commercializing promising Japanese scientific discoveries, namely the creation of new companies that will assume the risks and potential rewards of developing such discoveries – either to the stage where big companies are interested in taking on development themselves, or to the stage where the new company can grow and continue innovating on its own. Based on examples of trying to move forward several promising biomedical discoveries, Dr. Kneller will sketch out a roadmap for commercializing promising biomedical discoveries by forming new companies – a roadmap that may offer some guideposts for startups in other industries. One of the basic points is that success depends upon the startups being internationally oriented from birth. This includes openness to overseas investment, and aiming for international validation, regulatory approval, and markets.
|Time and Date:
||April 2nd (Thursday) 19:00 – 21:00pm (Doors open at 18:30pm.)
||Roppongi Hills Club, 51fl, Roppongi Hills Mori Tower, 6-10-1 Roppongi, Minato-ku
||5,000 yen includes standing buffet dinner with cash bar for all beverages.
||Please use the form on the right side of the page.
Please register by March 28th. Cancellations after that date and no-shows will be invoiced.
Professor Kneller’s research has focused on startups, entrepreneurship, intellectual property, university-industry technology transfer, and the importance of these factors for innovation and the development of biomedical discoveries for public benefit. He is board certified in General Preventive Medicine having completed his residency and public health studies in Johns Hopkins University. His MD is from Mayo Medical School (1984). He has a JD from Harvard Law School (1980). From 1988 to 1997 he worked in the US National Institutes of Health, first as a cancer epidemiologist, then in science policy, and finally at the coordinator for clinical cooperative R&D agreements with industry to develop NIH cancer drugs. He has worked in China on epidemiology studies and in clinical medicine and public health.